Full text is available at the source.
REV-ERBβ is required to maintain normal wakefulness and the wake-inducing effect of dual REV-ERB agonist SR9009
REV-ERBβ is needed for normal wakefulness and for the wake-promoting effect of the drug SR9009
AI simplified
Abstract
REV-ERBβ deficiency is associated with altered gene expression and impaired maintenance of wakefulness.
- Circadian signaling influences various physiological and behavioral processes, including sleep and wakefulness.
- REV-ERBβ is implicated in maintaining wakefulness during the activity period.
- Mice lacking REV-ERBβ did not exhibit increased wakefulness when treated with a specific REV-ERB agonist.
- Gene expression related to sleep and wakefulness is altered in mice deficient in REV-ERBβ.
AI simplified